A
ADIL
Adial Pharmaceuticals, Inc Common Stock
$3.00
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Adial Pharmaceuticals, Inc Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$16.57
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.68
Nov 11
Posts
No posts about ADIL yet.
About Adial Pharmaceuticals, Inc Common Stock
Adial Pharmaceuticals is a small drug developer that has no approved products to sell. Our data feed gives only an industry label (pharmaceuticals) and no company description, so this write-up leans on general knowledge: the company has worked on experimental treatments for alcohol use disorder. It earns no sales today and pays its bills by selling new shares to investors.